Resistance to β-lactams in Enterobacteriaceae, associated with plasmid-mediated extended-spectrum β-lactamases (ESBLs), has become a worldwide problem. The aim of this study is to estimate the prevalence of E. coli ESBLproducing gene in Iran. A comprehensive study and determination of the epidemiology of these genes in the community are necessary to control of ESBLs in the country. We searched international and national databases, including: PubMed, Scopus, Irandoc, Magiran, SID from 2008 to 2018, also available Congress of Iranian Medical Microbiology, for articles and abstracts describing the prevalence of genes encoding ESBL among clinical isolates of E. coli in Iran. Finally, sixty-eight studies that met our inclusion criteria were included in this meta-analysis, the outcome was combined using a random-effects model these were constructed for the event rate of genes encoding ESBL among clinical isolates of E. coli. Data were analyzed with the comprehensive Meta-Analysis (Ver2) software and the heterogeneity of studies was assessed using the I 2 index. The prevalence rate of bla TEM encoding ESBL in E. coli was 51% [summary: 95% CI = 46-57, I 2 = 78.66, df (Q) = 30, Q-value = 140.589, P < 0.49] and prevalence of bla SHV was reported 37% [summary: 95% CI = 30-45, I 2 = 83.35, df (Q) = 22, Qvalue = 132.147, P < 0.003]. The frequency of bla CTX-M gene among ESBL producing E. coli isolates was 45% [summary: 95% CI = 36-55, I 2 = 93.65, df (Q) = 27, Q-value = 425.553, P < 0.37]. The small number of studies limited power to detect associations and sources of heterogeneity. According to the result of this metaanalysis, the prevalence rate of ESBLs has been significantly increased in different regions of Iran, so this result could be useful to find a strategic policy for reducing the prevalence of ESBLs-producing E. coli.
Introduction
Resistance to β-lactams in Enterobacteriaceae, associated with plasmid-mediated extended-spectrum β-lactamases (ESBLs), has become a worldwide problem. ESBLs are characterized by their ability to hydrolyze β-lactams such as 3 and 4 generation cephalosporins, 7alpha-methoxy-cephalosporins (cephamycins), and aztreonam, but they remain susceptible to fosfomycin, nitrofurantoin, and carbapenems and most of them prevented by β-lactamase inhibitors such as clavulanic acid, sulbactam, and tazobactam. β-Lactamase genes (bla) were originally found to be chromosomal, since the emergence of the first reports on plasmid-borne bla TEM-1 in the 1960s.Up to now, > 600 variants of ESBLs have been identified, and these are categorized in several groups based on their amino acid sequences such as, temoneira (TEM), sulfhydryl variable (SHV), cefotaxime hydrolyzing capabilities (CTX-M) and oxacillin hydrolyzing (OXA) with 474, 193, 103 and19 variants, respectively. Other plasmid-mediated ESBLs, for example GES, PER, VEB are rare and have been found at a limited parts of the world, but all of these genes have been reported in E. coli in Iran. Determination of ESBL genes by molecular techniques in bacteria that produce ESBL and their antimicrobial resistance patterns can provide applicable information about their epidemiology and risk factors related to their infections. Rapid and correct detection in clinical laboratories is essential to find the most appropriate treatment for antimicrobial resistant organisms. In a study conducted in Iran, it was found that ESBL-producing prevalence is high in all parts of the country and the most ESBL-producing bacterium in Iran is E. coli. There are several studies that demonstrate the prevalence of ESBLs in developing countries, such as, East Africa (42%), Pakistan (40%), Israel (> 50%) and China (46%) are higher than in developed countries including, German (4 to 12%) and US (4 to 12%). This variation in the distribution and incidence of ESBL is maybe due to several factors, such as the economic and social situation of a community, antibiotics available, also, sensitivity and specificity of the methods used in determining of ESBL are contributing factors (Oduro-Mensah et al., 2016; Geser et al., 2012; Leylabadlo et al., 2017) .The aim of this study is to review and estimate the prevalence of E. coli ESBL-producing gene in Iran both in hospital and community settings during last 10 years (2008-2017) reference lists of relevant papers to locate additional studies that were not identified by the database searches ( Fig. 1 ).
Methods

Literature search
This Systematic review and meta-analysis were conducted to evaluate the frequency of E. coli, ESBL-producing gene in Iran during 2008 to 2018. We searched databases such as PubMed, Scopus (English language), Irandoc, available Congress of Iranian Medical Microbiology, two Iranian search engines such as Magiran and Iranian Scientific Information Database to identify related articles and the bibliographies of founded articles reviewed manually to find additional relevant studies. We collected both published and unpublished literature in Persian and English languages. Articles were reviewed by two separate investigators and eligible publications which were read in full text were chosen. The keyword used for English and Persian databases were equivalent and including: Extended spectrum beta-lactamase OR beta-lactamase OR ESBL AND Escherichia coli OR E. coli OR Enterobacteriaceae OR Gram-negative bacteria AND Iran. 
Inclusion and exclusion criteria
Inclusion criteria
Articles with the following criteria were added to this study: the articles which reviewed E. coli and ESBL-producing isolate were collected from inpatients and outpatient of Iranian hospitals included;
because this review study is limited to measure the prevalence of gene causing ESBL-producing E. coli in Iran. Also, studies using human samples were selected and included.
Exclusion criteria
Articles with the following criteria were excluded from this study; articles with unrelated topics as well as that used environmental samples were excluded. Studies that showed the percentage of ESBL-producing genes in all E. coli isolate. The duplicate publication which founded in several databases or published both in English and Persian databases excluded too.
Data extraction
We study the full texts or abstracts of the chosen articles and the following items were extracted from each article; first author, city, study period, published year, sample size, resistance genes, and the percent of resistance genes (Table 1) .
Quality assessment and statistical analysis
Statistical analyses were performed using the Comprehensive Meta-Analysis (Version 2). The total number of E. coli isolate that was ESBL positive were used as the sample size for each study and the number of genes reported in studies used as events. For assessing heterogeneity between studies we were used I-squared test and Beggs funnel plots used as a visual aid for detecting publication bias or systematic heterogeneity. Fig. 4 . Forest plot of meta-analysis for prevalence rate of bla-SHV coding ESBL in Escherichia coli with 37% (95% CI, 30-45) using random effects model. 
Result
Characteristics of included studies
According to the aforementioned search strategy, initially 952 search results identified through electronic databases and all of them were reviewed, based on title and abstract, after screening relevant record by title and abstract we removed duplicate and inappropriate articles, eventually after adding 20 records from available Congress of Iranian Medical Microbiology and article founded in search by hand we obtain 68 records for inclusion to Meta-analysis study (Fig. 1) . Characteristics of the included articles were presented in (Table 1) . Selected articles obtained from almost all provinces of Iran and most of them were performed in the capital of Iran (Tehran) (Fig. 10) . Samples were cultured from inpatients and outpatients, men and women with different ages and were collected from various clinical samples including, urine, stool, wound, blood, respiratory tube, sputum, abdominal fluid, bronchoalveolar, etc. The prevalence of gene coding ESBL in the clinical samples in order of frequency including, blood (> 80%), urine (> 75%), wound (> 74), sputum (> 68%). All of the ESBL-positive isolates in selected articles were identified by double-disc synergy test (DDST) and PCR used for detection of encoding genes with specific primers. 
Prevalence of gene encoding ESBL in clinical isolates of E. coli and risk of bias assessment
We examined the prevalence of genes encoding ESBL that the most studies were done on them in isolates of E. coli such as, bla TEM , bla CTX-M , bla SHV , bla VEB , and bla CTX-M family. The estimation of overall 31 article in our analysis showed that the prevalence rate of bla TEM encoding ESBL in E. coli is about 51% (95% CI = 46-57), in the Iranian patient (Figs. 2 & 3) and the heterogeneity between studies was (I 2 = 78.66, P < 0.49) (Fig. 10) . The prevalence rate of bla SHV encoding ESBL in E. coli was reported 37% (95% CI, 30-45), according to estimates of 23 papers (Figs. 4 & 5) and the heterogeneity between studies was (I 2 = 83.35; Fig. 8 . Forest plot of meta-analysis for prevalence rate of bla-CTX.M family coding ESBL in Escherichia coli with 54% (95% CI: 40-68) using random effects model. Fig. 9 . Funnel plot of the meta-analysis on the prevalence of bla-CTX.M family coding ESBL in Escherichia coli. P < 0.003).
By reviewing 28 articles, the pooled frequency of bla CTX-M gene among ESBL producing E. coli isolates was 45% [95% CI: 36-55%] (Figs. 6 & 7) . The heterogeneity test showed that there were high heterogeneities among this studies (I 2 = 93.65; P < 0.37). The estimation of overall 29 article in our analysis showed that the prevalence rate of bla CTX-M genes encoding ESBL including (bla CTX-M1 , bla CTX-M2 , bla CTX-M3 , bla CTX-M4 , bla CTX-M5 , bla CTX-M8 , bla CTX-M9 , bla CTX-M12 , bla CTX-M15 ) in E. coli is about 54% (95% CI: 40-68%). Among the studies, bla CTX-M1 had the most reports. The heterogeneity between studies was (I 2 = 95.13%; P < 0.50) Fig. 8 & 9) .
Discussion
In recent decades there has been an increased incidence and prevalence of resistance to β-lactams in Enterobacteriaceae, which due to the plasmid-mediated extended-spectrum β-lactamases (ESBLs). Enzymes that hydrolyze by this plasmid are the leading cause of resistance to the wide range of antibiotics including, 3 and 4 generations cephalosporin's, 7-alpha-methoxy-cephalosporins (cephamycins), and aztreonam. However, these are still susceptible to fosfomycin, nitrofurantoin, and carbapenems. In our knowledge, this is the first and the only systematic review and meta-analysis on the ESBL encoding gene on E. coli in Iran. According to the analyses performed in this systematic review of 68 articles, the prevalence rate of bla TEM (51%) is more than the other gene in different parts of Iran, so due to our study results the TEM β-lactamase gene, for ESBLs-producing E. coli, was highly endemic in Iran. According to reports, it is more prevalent in Kerman than other cities of Iran, and in a provincial perspective, Isfahan and Hamedan showed the lowest prevalence rate of bla TEM .
After that, the bla CTX-M (45%) and the bla SHV (37%) are respectively the most prevalent. There are other ESBL enzymes among E. coli such as VEB that according to the analyses of 6 article the frequency of it obtained low and 10% [95% CI: 4-22%] with heterogeneity (I 2 = 78.57%; P < 0.001).
In a study conducted in Iran (Leylabadlo et al., 2017) , it was founded that ESBL-producing prevalence is high in all parts of the country and the most ESBL-producing bacterium in Iran is E. coli and we understood that up to 89.8% of this isolates were ESBL positive (Leylabadlo et al., 2017) . Reviewing other studies showed a lower percentage of ESBL-producing E. coli in those countries compared to Iran, including, China 24.2%, Istanbul 60.5% and Nepal 38.9%, so this rate is alarmingly high in Iran (Parajuli et al., 2017; Senbayrak et al., 2017; To et al., 2013) . Therefore, we conclude that the most founded ESBL-producing bacteria in Iran are E. coli encoded with bla TEM .
A meta-analysis or comprehensive study with high sample size has not been reported in humans worldwide. In 2017, a study with a low sample size reported the gene CTX-M-15 being most prevalent in ESBLproducing Enterobacteriaceae in various countries of Africa. CTX-M ESBLs are a heterogeneous family and show the current situation in different geographic areas, some of the members of CTX-M enzymes family are present in a specific area such as CTX-M-9, CTX-M-14, CTX-M-1, and CTX-M-2 genes, but others such as CTX-M-15 have been observed in almost all part of the world (Saravanan et al., 2018) . According to the reviewing 7 articles the outbreak rate of CTX-M-15 is 48% [95% CI: 18-83%]. The study by Kanamori reported more prevalence of CTX-M toward bla TEM in clinical isolates of Enterobacteriaceae from the Philippines (Kanamori et al., 2011) .
The comparison between the results of our study and other authors shows that the prevalence of different type of genes varies in different geographic regions. A meta-analysis study by Abrar was performed to determine the prevalence of ESBL producing Enterobacteriaceae in Pakistan and their findings were similar to ours that CTX-M, SHV, TEM, and OXA, were the most commonly found gene variants for ESBLs in their studies but, the percentage of each gene was not determined (Abrar et al., 2018) .
Limitations
Our study has some limitations that we should discuss them, due to the high heterogeneity between the results of our study, we have to eliminate a number of studies for each gene, and these studies had the different outcome than other studies. This may be because of the false sampling or misconduct of the method.
Conclusion
Despite all mentioned limitation, the present meta-analysis demonstrated that the prevalence of ESBL-producing E. coli in Iran, like many other parts of the world, has been significantly increased. According to the analyses performed in this meta-analysis of 68 articles, the prevalence of genes encoding ESBL including, bla SHV (37%), bla CTX-M (45%) and bla TEM more than the other gene in different parts of Iran with the prevalence rate approximately 51%. Thus, due to our study results the TEM β-lactamase gene, for ESBLs-producing E. coli, was highly endemic in Iran. The result of this meta-analysis could be helpful to find a strategic policy for reducing the prevalence of ESBLs-producing E. coli.
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